相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A new checkpoint against ferroptosis
Deguang Liang et al.
CELL RESEARCH (2020)
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
Xuexian Fang et al.
CIRCULATION RESEARCH (2020)
The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor
Hai-Lian Bi et al.
SCIENCE ADVANCES (2020)
Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload
Junyan Wang et al.
CELL DEATH & DISEASE (2020)
The tumor suppressor protein p53 and the ferroptosis network
Rui Kang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis
Chunjia Li et al.
CELL DEATH AND DIFFERENTIATION (2019)
Ferroptosis as a target for protection against cardiomyopathy
Xuexian Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance
Jonathan K. M. Lim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation
Xin Xie et al.
SCIENCE ADVANCES (2019)
Genetic Ablation of the Cystine Transporter xCT in PDAC Cells Inhibits mTORC1, Growth, Survival, and Tumor Formation via Nutrient and Oxidative Stresses
Boutaina Daher et al.
CANCER RESEARCH (2019)
Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes
Tae-Jun Park et al.
CELL DEATH & DISEASE (2019)
Ferroptosis and Its Role in Diverse Brain Diseases
Abigail Weiland et al.
MOLECULAR NEUROBIOLOGY (2019)
Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes
Yuichi Baba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Metabolic Coordination of Physiological and Pathological Cardiac Remodeling
Andrew A. Gibb et al.
CIRCULATION RESEARCH (2018)
PICK1 deficiency exacerbates sepsis-associated acute lung injury and impairs glutathione synthesis via reduction of xCT
Meizi Qian et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
The cystine-glutamate exchanger (xCT, Slc7a11) is expressed in significant concentrations in a subpopulation of astrocytes in the mouse brain
Sigrid Ottestad-Hansen et al.
GLIA (2018)
Oxidative Stress and Cardiac Remodeling: An Updated Edge
Abeer M. Rababa'h et al.
CURRENT CARDIOLOGY REVIEWS (2018)
Cardiac structural remodeling in hypertensive cardiomyopathy
Si-jia Sun et al.
HYPERTENSION RESEARCH (2017)
Characterization of Ferroptosis in Murine Models of Hemochromatosis
Hao Wang et al.
HEPATOLOGY (2017)
Hypertension, left ventricular hypertrophy, and sudden cardiac death
Mohammad Shenasa et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility
Chun-Shik Shin et al.
NATURE COMMUNICATIONS (2017)
SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy
Xiaoqiang Tang et al.
CIRCULATION (2017)
Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease
Karl T. Weber et al.
AMERICAN JOURNAL OF HYPERTENSION (2017)
Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling
Yulin Li et al.
CIRCULATION (2017)
Ferrootosis: Death by Lipid Peroxidation
Wan Seok Yang et al.
TRENDS IN CELL BIOLOGY (2016)
Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis
Tina Sehm et al.
ONCOTARGET (2016)
Is Inhibition of Hypertrophy a Good Therapeutic Strategy in Ventricular Pressure Overload?
Gabriele G. Schiattarella et al.
CIRCULATION (2015)
The Cystine/Glutamate Antiporter System xc- in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
Jan Lewerenz et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
The oxidative stress-inducible cystine/glutamate antiporter, system xc-: cystine supplier and beyond
Marcus Conrad et al.
AMINO ACIDS (2012)
Cardiac remodeling at the population level -risk factors, screening, and outcomes
Ola Gjesdal et al.
NATURE REVIEWS CARDIOLOGY (2011)
Remodelling of the heart and vessels in experimental hypertension: advances in protection Introduction
Fedor Simko et al.
JOURNAL OF HYPERTENSION (2010)
Aggravation of ischemia-reperfusion-triggered acute renal failure in xCT-deficient mice
Tomohiro Shibasaki et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
Angiotensin II-induced p53-dependent cardiac apoptotic cell death: Its prevention by metallothionein
Qiuju Liu et al.
TOXICOLOGY LETTERS (2009)
The xc- cystine/glutamate antiporter:: A potential target for therapy of cancer and other diseases
Maisie Lo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
ROS as signalling molecules:: mechanisms that generate specificity in ROS homeostasis
Benoit D'Autreaux et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Role of oxidative stress in cardiac hypertrophy and remodeling
Eiki Takimoto et al.
HYPERTENSION (2007)